Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/5/2026

Guideline Summary for Activated Charcoal Use in Poisoning

Mechanism of Action

  • Activated charcoal reduces systemic absorption of ingested toxins by adsorbing them onto its large surface area; it works by adsorption rather than acting as a true antidote. 1

Indications & General Dosing

Pediatric Emergency Dosing

  • For children, give 1–2 g/kg of activated charcoal orally or via nasogastric tube as the initial dose. [2][3]

Adolescent/Adult Emergency Dosing

  • For patients older than 12 years (including adults), administer a single dose of 50–100 g of activated charcoal. [2][3]

Substances Not Effectively Adsorbed

  • Activated charcoal should not be used for ingestions of iron, lithium, alcohols, ethylene glycol, alkalis, fluoride, mineral acids, or potassium because these agents are not bound by charcoal. [2][3]

Special Situations

Acetaminophen Overdose (within 4 h of ingestion)

  • Give 1 g/kg of activated charcoal as a slurry immediately before starting N‑acetylcysteine therapy.
  • The greatest benefit occurs when charcoal is given within 1 hour of ingestion, but clinically useful reduction may still be seen up to 3–4 hours. [4][5]6

Amanita phalloides (mushroom) Poisoning

  • When presentation is early with gastrointestinal symptoms, administer activated charcoal via nasogastric tube together with gastric lavage. [5][6]

Timed‑Release or Enterohepatic Drugs

  • For delayed‑release formulations, a dose of activated charcoal can be given up to 6 hours after ingestion to interrupt ongoing absorption. [derived from timing data; no explicit citation]

Preparation & Administration

Slurry Preparation

  • Mix activated charcoal powder with water to create a uniform slurry; use at least 8 oz of liquid for the specified dose. [4][5]6

Route of Delivery

  • Oral ingestion is preferred; if the patient cannot swallow, deliver the slurry through a nasogastric tube. [4][5]6

Timing of Administration

  • Administer as soon as possible, ideally within the first hour after ingestion, because efficacy declines sharply with time (≈ 47 % reduction in absorption at 30 min, ≈ 40 % at 60 min, ≈ 16 % at 120 min, and ≈ 21 % at 180 min). [no citation – omitted]

Contraindications & Limitations

Absolute Contraindications

  • Do not give activated charcoal to patients with an unsecured airway (e.g., impaired consciousness, seizures) because of high aspiration risk. [no citation – omitted]

First‑Aid Setting (Class IIb Recommendation)

  • The American Heart Association and American Red Cross (2010) advise against routine use of activated charcoal in first‑aid situations unless directed by a poison‑control center or emergency medical personnel; evidence of benefit is lacking and reports of harm exist. [7][8]9

Clinical Recommendations

Consultation

  • Prior to administration, always contact the regional poison‑control center for guidance on appropriateness and dosing. [2][3]
  • Clinical toxicologists can provide expert advice on complex cases. 10

Sorbitol Co‑administration

  • Avoid routine use of sorbitol‑containing charcoal preparations.
  • Use non‑sorbitol formulations for infants (< 1 year) and when repeated doses are required, as sorbitol has been linked to fatal hypernatremic dehydration with multiple dosing. [2][3]

Monitoring After Administration

  • Keep the patient upright and active; monitor closely for signs of aspiration, especially in those with altered mental status, and be prepared to secure the airway if needed. [2][3]

Activated Charcoal Guidelines

Direct Oral Anticoagulant (DOAC) Overdose

  • Single‑dose regimen: Administer 50 g of activated charcoal orally to adults who have ingested a DOAC (e.g., apixaban or rivaroxaban) within 8 hours of exposure. This dose is recommended only when the ingestion occurred less than 8 hours prior. [11][12]
  • Pharmacokinetic benefit: In controlled studies with healthy volunteers, a single 50 g dose of activated charcoal significantly lowered plasma concentrations of apixaban when given up to 6 hours after ingestion and rivaroxaban when given up to 8 hours after ingestion. The reduction was clinically meaningful, supporting its use as an early de‑contamination measure. [11][12]

Multiple‑Dose Activated Charcoal for Specific Toxicants

  • Aspirin (acetyl‑salicylic acid) poisoning: Moderate‑to‑high quality evidence supports the use of repeated activated‑charcoal doses (initial 75–100 g followed by 50 g every 4 hours) to enhance drug elimination in severe aspirin overdose. 12
  • Phenytoin poisoning: Moderate‑to‑high quality evidence indicates that multiple‑dose activated charcoal (initial 75–100 g then 50 g every 4 hours) improves clearance of phenytoin in intoxicated patients. 12

REFERENCES